Acadia Pharmaceuticals (ACAD) Retained Earnings (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly Retained Earnings of -$1.8 billion for Q1 2026, down 414230.21% year-over-year from N/an in Q1 2025, and down 125342.15% quarter-over-quarter from $1.4 million in Q4 2025.
Acadia Pharmaceuticals (ACAD) Retained Earnings (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Retained Earnings history runs 17 years deep, the most recent figure standing at -$1.8 billion for Q1 2026.
- In Q1 2026, Retained Earnings fell 414230.21% year-over-year to -$1.8 billion; the TTM figure through Mar 2026 stood at -$1.8 billion (down 414230.21% YoY), while the FY2025 annual figure was $1.4 million, up 394.86% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1.8 billion, down from $1.4 million in the prior quarter.
- The five-year high for Retained Earnings was $1.4 million in Q4 2025, with the low at -$2.4 billion in Q4 2023.
- The 5-year median for Retained Earnings is -$339000.0 (2024), against an average of -$941.1 million.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings jumped 394.86% in 2025, then tumbled 414230.21% in 2026.
- Acadia Pharmaceuticals' Retained Earnings stood at -$2.4 billion in 2022, then decreased by 2.59% to -$2.4 billion in 2023, then jumped by 100.01% to $292000.0 in 2024, then jumped by 394.86% to $1.4 million in 2025, then plunged by 125342.15% to -$1.8 billion in 2026.
- Business Quant data shows ACAD's Retained Earnings at -$1.8 billion in Q1 2026, $1.4 million in Q4 2025, and $989000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Acadia Pharmaceuticals | 4.86 Bn | 3.90 Bn | 279.64 Mn | -1.78 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.78 Bn |
| Mar 31, 2026 | -1.81 Bn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 989,000.00 |
| Jun 30, 2025 | 406,000.00 |
| Mar 31, 2025 | 437,000.00 |
| Dec 31, 2024 | 292,000.00 |
| Sep 30, 2024 | 858,000.00 |
| Jun 30, 2024 | -339,000.00 |
| Mar 31, 2024 | -229,000.00 |
| Dec 31, 2023 | -2.43 Bn |
| Sep 30, 2023 | -319,000.00 |
| Jun 30, 2023 | -2.41 Bn |
| Mar 31, 2023 | -2.41 Bn |
| Dec 31, 2022 | -2.37 Bn |
| Sep 30, 2022 | -1.37 Mn |
| Jun 30, 2022 | -2.30 Bn |
| Mar 31, 2022 | -2.27 Bn |
| Dec 31, 2021 | -2.15 Bn |
| Sep 30, 2021 | -2.11 Bn |